Novartis’ Indian Patent Challenge Could Harm: MSF

Law360, New York (September 26, 2006, 12:00 AM EDT) -- International aid organization Medecins Sans Frontieres lashed out at Novartis AG on Tuesday, saying the Swiss drug maker’s challenge to a key section of India’s recently enacted patent laws could seriously impact future access to essential medicines in other nations.

"If Novartis' challenge against the Indian patent law is successful, a key safeguard that can protect the production of affordable medicines will be lost," said Ellen 't Hoen, policy director at MSF's Campaign for Access to Essential Medicines. "People the world over who rely on India...
To view the full article, register now.